NVNO offering history
Every offering-related filing in enVVeno Medical Corp’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 407 filings back to Dec 15, 2015.
| Date | Filing | What it means | |
|---|---|---|---|
| Oct 30, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Mar 14, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Mar 12, 2025 | S-3/A → | REGISTERED | S-3/A registration — capacity to sell shares, not a sale yet |
| Feb 28, 2025 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Sep 30, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Sep 27, 2024 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Sep 26, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Nov 3, 2023 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Oct 26, 2023 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Oct 12, 2023 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Aug 23, 2023 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Aug 14, 2023 | S-3/A → | REGISTERED | S-3/A registration — capacity to sell shares, not a sale yet |
| Jul 31, 2023 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| May 5, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Sep 8, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 12, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 6, 2021 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| May 6, 2021 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Feb 10, 2021 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Feb 8, 2021 | S-1MEF → | REGISTERED | S-1MEF registration — capacity to sell shares, not a sale yet |
| Feb 8, 2021 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Feb 5, 2021 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Feb 5, 2021 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Feb 3, 2021 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Jan 29, 2021 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Jan 28, 2021 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Dec 21, 2020 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Nov 30, 2020 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Nov 24, 2020 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Nov 24, 2020 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Nov 6, 2020 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Oct 22, 2020 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Oct 8, 2020 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Oct 8, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Oct 5, 2020 | S-3/A → | REGISTERED | S-3/A registration — capacity to sell shares, not a sale yet |
| Sep 17, 2020 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Jul 21, 2020 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jul 20, 2020 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Jul 16, 2020 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Jul 16, 2020 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
NVNO offering FAQ
When did NVNO last execute an offering?
Per SEC filings, enVVeno Medical Corp's most recent priced offering document is a 424B5 filed 2025-10-30. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did NVNO last announce or register an offering?
The most recent registration is a S-3/A filed 2025-03-12. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.